12/5
09:10 am
zts
Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats [Yahoo! Finance]
Low
Report
Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats [Yahoo! Finance]
12/5
08:30 am
zts
Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats
Low
Report
Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats
12/4
10:58 am
zts
Zoetis Inc. (ZTS): A Bull Case Theory [Yahoo! Finance]
Low
Report
Zoetis Inc. (ZTS): A Bull Case Theory [Yahoo! Finance]
12/3
08:06 am
zts
Zoetis (NYSE:ZTS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $160.00 price target on the stock.
Low
Report
Zoetis (NYSE:ZTS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $160.00 price target on the stock.
12/2
11:46 am
zts
Zoetis Inc. (ZTS) Discusses R&D Pipeline Progress and Strategic Vision in Animal Health Innovation Transcript [Seeking Alpha]
Low
Report
Zoetis Inc. (ZTS) Discusses R&D Pipeline Progress and Strategic Vision in Animal Health Innovation Transcript [Seeking Alpha]
12/2
07:30 am
zts
Zoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast
Low
Report
Zoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast
11/26
04:15 pm
zts
Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
Low
Report
Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
11/20
05:05 pm
zts
Zoetis (NYSE:ZTS) is now covered by analysts at KeyCorp. They set a "sector weight" rating on the stock.
Medium
Report
Zoetis (NYSE:ZTS) is now covered by analysts at KeyCorp. They set a "sector weight" rating on the stock.
11/20
08:30 am
zts
Zoetis to Participate in the Piper Sandler 37th Annual Healthcare Conference
Low
Report
Zoetis to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/19
08:30 am
zts
Zoetis to Host Innovation Webcast
Low
Report
Zoetis to Host Innovation Webcast
11/19
06:04 am
zts
Feeling the GLP-1 Gut Shift? These 23 Probiotics Actually Help [Los Angeles Times (CA)]
Low
Report
Feeling the GLP-1 Gut Shift? These 23 Probiotics Actually Help [Los Angeles Times (CA)]
11/18
08:14 am
zts
Zoetis (NYSE:ZTS) had its price target lowered by analysts at Stifel Nicolaus from $140.00 to $130.00. They now have a "hold" rating on the stock.
Low
Report
Zoetis (NYSE:ZTS) had its price target lowered by analysts at Stifel Nicolaus from $140.00 to $130.00. They now have a "hold" rating on the stock.
11/16
06:16 am
zts
Zoetis Inc. (NYSE:ZTS) Shares Could Be 32% Below Their Intrinsic Value Estimate [Yahoo! Finance]
Low
Report
Zoetis Inc. (NYSE:ZTS) Shares Could Be 32% Below Their Intrinsic Value Estimate [Yahoo! Finance]
11/15
07:05 pm
zts
2 Outstanding Dividend Stocks That Are Too Cheap to Ignore [Yahoo! Finance]
Low
Report
2 Outstanding Dividend Stocks That Are Too Cheap to Ignore [Yahoo! Finance]
11/14
11:38 am
zts
Zoetis: A High-Quality Compounder Now On Sale? [Forbes]
Low
Report
Zoetis: A High-Quality Compounder Now On Sale? [Forbes]
11/12
08:07 am
zts
Zoetis (NYSE:ZTS) had its price target lowered by analysts at BTIG Research from $200.00 to $160.00. They now have a "buy" rating on the stock.
Low
Report
Zoetis (NYSE:ZTS) had its price target lowered by analysts at BTIG Research from $200.00 to $160.00. They now have a "buy" rating on the stock.
11/11
09:46 am
zts
RION Launches Rion Vet to Transform Animal Health with First-in-Class Exosome Biologics; Appoints Industry Leader Mark Herthel as CEO; Announces Series A Fulfillment [Yahoo! Finance]
Low
Report
RION Launches Rion Vet to Transform Animal Health with First-in-Class Exosome Biologics; Appoints Industry Leader Mark Herthel as CEO; Announces Series A Fulfillment [Yahoo! Finance]
11/10
01:48 pm
zts
Zoetis (NYSE:ZTS) had its price target lowered by analysts at Morgan Stanley from $211.00 to $175.00. They now have an "overweight" rating on the stock.
Low
Report
Zoetis (NYSE:ZTS) had its price target lowered by analysts at Morgan Stanley from $211.00 to $175.00. They now have an "overweight" rating on the stock.
11/7
12:07 pm
zts
Zoetis: Why I'm Still Holding The Stock But Advise Against New Positions [Seeking Alpha]
Low
Report
Zoetis: Why I'm Still Holding The Stock But Advise Against New Positions [Seeking Alpha]
11/5
06:38 pm
zts
Zoetis (NYSE:ZTS) had its price target lowered by analysts at UBS Group AG from $158.00 to $141.00. They now have a "neutral" rating on the stock.
Low
Report
Zoetis (NYSE:ZTS) had its price target lowered by analysts at UBS Group AG from $158.00 to $141.00. They now have a "neutral" rating on the stock.
11/5
06:19 pm
zts
Diamond Hill Capital's Strategic Moves: A Closer Look at Zoetis Inc. [Yahoo! Finance]
Low
Report
Diamond Hill Capital's Strategic Moves: A Closer Look at Zoetis Inc. [Yahoo! Finance]
11/5
05:10 pm
zts
This Animal Health Stock Tanks on Earnings. Pig and Chicken Medication Revenue Slumps. [Yahoo! Finance]
Low
Report
This Animal Health Stock Tanks on Earnings. Pig and Chicken Medication Revenue Slumps. [Yahoo! Finance]
11/5
03:27 pm
zts
Zoetis (NYSE:ZTS) had its price target lowered by analysts at JPMorgan Chase & Co. from $230.00 to $200.00. They now have an "overweight" rating on the stock.
Low
Report
Zoetis (NYSE:ZTS) had its price target lowered by analysts at JPMorgan Chase & Co. from $230.00 to $200.00. They now have an "overweight" rating on the stock.
11/4
03:02 pm
zts
Zoetis (NYSE:ZTS) was given a new $140.00 price target on by analysts at Stifel Nicolaus.
Low
Report
Zoetis (NYSE:ZTS) was given a new $140.00 price target on by analysts at Stifel Nicolaus.
11/4
12:44 pm
zts
Zoetis: No Longer A Growth Stock [Seeking Alpha]
Low
Report
Zoetis: No Longer A Growth Stock [Seeking Alpha]